Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ADIL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ADIL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Adial Pharmaceuticals Inc

ADIL
Current price
0.39 USD -0.025 USD (-6.10%)
Last closed 0.41 USD
ISIN US00688A1060
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 6 468 119 USD
Yield for 12 month -65.32 %
1Y
3Y
5Y
10Y
15Y
ADIL
21.11.2021 - 28.11.2021

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia. Address: 4870 Sadler Road, Glen Allen, VA, United States, 23060

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.00 USD

P/E Ratio

Dividend Yield

Financials ADIL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ADIL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-564 USD

Current Quarter

Last Quarter

EBITDA -8 706 163 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -107.38 %
PEG Ratio
Return On Equity TTM -217.01 %
Wall Street Target Price 4.00 USD
Revenue TTM
Book Value 0.32 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.87 USD
Diluted Eps TTM -0.87 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ADIL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.49
Price Book MRQ 2.36

Technical Indicators ADIL

For 52 Weeks

0.22 USD 1.37 USD
50 Day MA 0.53 USD
Shares Short Prior Month 490 072
200 Day MA 0.82 USD
Short Ratio 0.55
Shares Short 933 683
Short Percent 4.74 %